HDT bio's Rapid-Response Roadmap for RNA vaccines (R4) project granted a five-year subaward for $2M per year SEATTLE, Sept. 17, 2024 /PRNewswire/ -- HDT Bio Corp., a clinical-stage ...

HDT bio's Rapid-Response Roadmap for RNA vaccines (R 4) project granted a five-year subaward for $2M per year SEATTLE, Sept. 17, 2024 /PRNewswire/ -- HDT Bio Corp., a clinical-stage ...

With COVID-19 still spreading and mpox emerging as a public health emergency of international concern, the National ...

Long known as a messenger within cells, RNA is increasingly seen as life’s molecular communication system — even between ...

Japan's health ministry has approved five types of coronavirus vaccines for use in this season's campaign that starts on October 1.

Plus, we'll look at the how gas prices can affect elections and do the numbers on the new COVID vaccine in this week's ...

The new company focuses on producing components needed to manufacture RNA-based therapies for which there is increasing ...

Modified nucleotides like m5C in saRNA enhance vaccine efficacy, stability, and reduce inflammation, offering a promising ...

A collaboration between four MIT groups, led by principal investigators Laura L. Kiessling, Jeremiah A. Johnson, Alex K.